Status:
WITHDRAWN
Time Frame for GBS Screening
Lead Sponsor:
Rambam Health Care Campus
Conditions:
GBS
Group B Streptococcal Infection
Eligibility:
FEMALE
18-45 years
Brief Summary
All pregnant women prenatally being followed up or admitted at Rambam HealthCare Campus, Haifa, Israel are potential participants in the study. If a patient is agreeable, the nurse/physician/research ...
Detailed Description
1. All pregnant women prenatally being followed up or admitted at Rambam HealthCare Campus, Haifa, Israel are potential participants in the study. 2. Most high-risk pregnant women have their routine f...
Eligibility Criteria
Inclusion
- Pregnant women that are being followed up prenatally or admitted at Rambam HealthCare Campus, Haifa, Israel and are planning to deliver there.
- Women at gestational age 300/7 or less.
Exclusion
- Age 18 and under.
- Women with previous delivery of an infant affected by GBS disease.
- Women with known bacteriuria in the current pregnancy.
- Women whom are planning not to deliver at Rambam HealthCare Campus.
- Women who will not consent to participate in the study.
Key Trial Info
Start Date :
November 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04116645
Start Date
November 1 2020
End Date
October 30 2024
Last Update
January 13 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.